<DOC>
	<DOCNO>NCT00002511</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell may effective treatment prostate cancer . PURPOSE : Randomized phase III trial compare radiation therapy treatment treat patient stage III prostate cancer follow radical prostatectomy .</brief_summary>
	<brief_title>Radiation Therapy Compared With No Further Treatment Following Surgery Treating Patients With Prostate Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare local recurrence rate , acute late morbidity , overall survival , disease-free survival , cancer-related survival patient pT3 pN0 adenocarcinoma prostate randomize follow radical prostatectomy postoperative conventional pelvic irradiation ( 60 Gy ) v treatment relapse . - Better define selective pathologic indication radiotherapy patient pT3 pN0 disease . OUTLINE : This randomize study . - Arm I : Patients undergo radiotherapy daily , 5 day week , 5 week , follow boost radiotherapy 1-1.4 week . - Arm II : Patients observe . Local relapse treat conventional pelvic radiotherapy . Patients follow every 3 month first postoperative year , every 6 month fifth year , annually thereafter . PROJECTED ACCRUAL : A total 1000 patient accrue study within 7.5 year .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically document invasive adenocarcinoma prostate stag pT3 pN0 radical prostatectomy Preoperative staging must T03 N0 M0 base physical exam , chest xray , bone scan , CT MRI entire pelvis abdomen , serum PSA At least 1 follow feature must present : Complete capsule invasion ( i.e. , perforation ) Positive surgical margin ( microscopic gross ) Seminal vesicle invasion Radiotherapy must begin within 16 week follow surgery , recovery urinary function PATIENT CHARACTERISTICS : Age : 75 Performance status : WHO 02 Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No malignancy PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : No 4 month preoperative hormonal therapy Radiotherapy : Not specify Surgery : Radical prostatectomy require within 12 week recovery urinary function</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>adenocarcinoma prostate</keyword>
	<keyword>stage I prostate cancer</keyword>
	<keyword>stage IIB prostate cancer</keyword>
	<keyword>stage IIA prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
</DOC>